Mitigating out-of-pocket costs for prescription drugs

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Elizabeth Anne Jackson, Matt Berman | 27 March 2017

A significant and growing number of commercially insured members have one or more chronic medical conditions that require multiple interactions with the healthcare system in a given year. And there has been a growth in the out-of-pocket costs associated with healthcare services. This analysis identifies tactics plan administrators could adopt that would reduce out-of-pocket costs for brand-name drugs.

This report was commissioned by Eli Lilly.